Fieldpoint Private Securities, LLC Hutchmed (China) LTD Transaction History

Fieldpoint Private Securities, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$8.59 - $20.77 $472 - $1,142	-55 Closed	0 $0
Q1 2022 Apr 07, 2022	SELL	$15.52 - $35.65 $2,638 - $6,060	-170 Reduced 75.56%	55 $1,000
Q4 2021 Jan 24, 2022	BUY	$28.89 - $35.33 $5,778 - $7,066	200 Added 800.0%	225 $8,000
Q2 2021 Aug 12, 2021	BUY	$23.7 - $39.27 $474 - $785	20 Added 400.0%	25 $1,000
Q4 2020 Jan 28, 2021	BUY	$27.51 - $34.36 $137 - $171	5 New	5 $0

8.25M

3.8K

2.4K

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $3.38B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Fieldpoint Private Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Fieldpoint Private Securities, LLC with notifications on news.